South Africa moves to substantive examination for pharma patents, amid fears system could grind to halt
New IP policy looks to get tough on evergreening in pharma industry but also brings country closer to international best practices.
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10